ASTM-F2065 2010

$40.63

F2065-00(2010) Standard Practice for Testing for Alternative Pathway Complement Activation in Serum by Solid Materials

Published By	Publication Date	Number of Pages
ASTM	2010	7

Guaranteed Safe Checkout

Categories: 11.040.40 - Implants for surgery, prosthetics and orthotics, ASTM

If you have any questions, feel free to reach out to our online customer service team by clicking on the bottom right corner. We’re here to assist you 24/7.
Email:[email protected]

Description

ASTM F2065-00-Reapproved2010

Withdrawn Standard: Standard Practice for Testing for Alternative Pathway Complement Activation in Serum by Solid Materials (Withdrawn 2016)

ASTM F2065

Scope

1.1 This practice provides a protocol for rapid, in vitro screening for alternative pathway complement activating properties of solid materials used in the fabrication of medical devices that will contact blood.

1.2 This practice is intended to evaluate the acute in vitro alternative pathway complement activating properties of solid materials intended for use in contact with blood. For this practice, “serum” is synonymous with “complement.”

1.3 This practice consists of two procedural parts. Procedure A describes exposure of solid materials to a standard lot of C4-deficient guinea pig serum [C4(-)GPS], using 0.1-mL serum per 13 × 100-mm disposable glass test tubes. Sepharose CL-4B is used as an example of test materials. Procedure B describes assaying the exposed serum for significant functional alternative pathway complement depletion as compared to control samples. The endpoint in procedure B is lysis of rabbit RBC in buffer containing EGTA and excess Mg⁺⁺.

1.4 This practice does not address function, elaboration, or depletion of individual complement components except as optional additional confirmatory information that can be acquired using human serum as the complement source. This practice does not address the use of plasma as a source of complement.

1.5 This practice is one of several developed for the assessment of the biocompatibility of materials. Practice F748 may provide guidance for the selection of appropriate methods for testing materials for other aspects of biocompatibility. Practice F1984 provides guidance for testing solid materials for whole complement activation in human serum, but does not discriminate between the classical or alternative pathway of activation.

1.6 The values stated in SI units are to be regarded as standard. No other units of measurement are included in this standard.

Keywords

alternative pathway; biocompatibility; blood compatibility; complement testing; materials; medical devices; Alternative pathway complement activation; Barbitol (veronal) buffer; Biocompatibility; Blood compatibility; Blood materials/applications; C-4 deficient Guidea Pig serum (C4-GPS); Complement activation; Fabrication (of medical devices); Medical devices/equipment; Rabbit RBC (red blood cells); Red blood cells (RBC); Screen analysis–medical/surgical applications; Serum; Sheep RBC (red blood cells); Solid phase materials; in vitro Evaluation

ICS Code

ICS Number Code 11.040.40 (Implants for surgery, prothetics and orthotics)

DOI: 10.1520/F2065-00R10

PDF Catalog

PDF Pages	PDF Title
1	Scope Referenced Documents Terminology
2	Summary of Practice Significance and Use Preparation of Buffers Preparation of Sheep and Rabbit RBC
3	Absorption of Serum (Complement) Whole Complement Titration to Determine Optimal Serum Dilution TABLE 1
4	Procedure A—Exposure of Material to C4(-)GPS
5	Procedure B—Assay of Serum for Alternative Pathway Complement Activation in Procedure A Necessary Controls
6	Report and Data Analysis Keywords X1. RATIONALE X1.1 X1.2
7	X1.3 X1.4 X1.5 X1.6 REFERENCES

Additional information

Standard Title	F2065-00(2010) Standard Practice for Testing for Alternative Pathway Complement Activation in Serum by Solid Materials
Published Code	ASTM
Publication Date	2010
Pages Count	7
ICS Codes	11.040.40 - Implants for surgery, prosthetics and orthotics